TY  - CHAP
M1  - Book, Section
TI  - Lipid Disorders
A1  - Papadakis, Maxine A.
A1  - McPhee, Stephen J.
A1  - Rabow, Michael W.
A1  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - There  remains  controversy  about  the  efficacy  of  omega-3  therapies,  since  the  2020  STRENGTH  trial  showed  no  CVD  benefit  of  omega-3  carboxylic  acids;  it  remains  unclear  if  this  result  was  due  to  a  different  omega-3  fatty  acid  preparation,  chance,  or  a  much  smaller  benefit  of  omega-3  fatty  acids  preparations  than  originally  demonstrated.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1183884843
ER  -